Kodak (KODK), Dealmed Partner on Infrared Thermometers
Medical supply manufacturer and distributor Dealmed today announced a licensing agreement with Eastman Kodak Company (NYSE: KODK) for the production of infrared thermometers This partnership represents a significant addition to Dealmed's rapidly expanding product offering and supply framework.
Dealmed, one of the northeast's oldest and most reputable medical supply distributors will channel their long-standing relationships and fortified supply lines to bring reliability and dependability to Kodak's product line.
"Dealmed has built itself on the promise of providing high-quality products quickly, efficiently and reliably. Through this partnership with Kodak we will be able to utilize our decades-long relationships within the medical supply industry to ensure that every product meets the incredibly high standard that Kodak is known for," said Michael Einhorn president of Dealmed.
The thermometers are set to be distributed and sold throughout the United States and South America. These devices utilize infrared technology to allow for efficient, non-contact temperature readings while still maintaining an exceptionally high level of accuracy.
This partnership with Dealmed will enable Kodak to expand its product offering to include new, high-quality medical equipment from a long-standing and trusted name in the medical supply space.
"We are excited to announce this licensing agreement with Dealmed to further expand Kodak's presence in the medical space," said Clara Fort Vice President of Global Brand Licensing for Kodak.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- Holcim to acquire Fermacell from James Hardie for EUR 840M
- Real and RE/MAX Holdings set Aug. 24 merger closing date
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share